Exercise may benefit colon cancer patients as much as some drugs: Study
- Researchers presented a randomized controlled trial at the 2025 ASCO meeting in Chicago showing exercise reduces colon cancer recurrence after treatment.
- The trial followed nearly 900 stage II and III patients for a median of 7.9 years, comparing exercise consultants to health education materials alone.
- Exercise reduced cancer recurrence risk by 28%, with five‑year disease‑free survival rates of 80% versus 74% for controls, indicating post‑treatment physical activity is effective.
- Dr. Christopher Booth said the survival benefits are "comparable to and in many cases exceed" many standard cancer drugs, underscoring exercise as an essential treatment component.
- These findings suggest integrating exercise into colon cancer care may improve outcomes and that lifestyle factors like diet and inflammation are key areas of ongoing research.
226 Articles
226 Articles
WEF Scientists Warn That Running Is Causing an Explosion in Unusual Cancers
WEF-funded Scientists are sounding the alarm that long-distance running, a favored activity among the health-conscious, may be linked to an alarming rise in unusual cancers, particularly colon cancer in younger adults. A new study suggests [...] The post WEF Scientists Warn That Running Is Causing an Explosion in Unusual Cancers appeared first on The People's Voice.
Exercise could help colon cancer patients just as much as some prescription drugs
Colorectal cancer is the second-deadliest form of cancer in the United States, according to the American Cancer Society (ACS). However, a new study shows regular exercise could play a role in possibly changing that. Colorectal cancer in the U.S. Copy URL Save image Email Facebook Twitter / X Reddit Unbiased. Straight Facts.TM In 2025, an estimated more than 150,000 Americans will be diagnosed with colorectal cancer. Nearly 5…
Regular exercise can reduce the risk of death in colon cancer patients by a third, prevent tumors from coming back, and in some cases be even more effective than many medications, according to a recent study.
Coverage Details
Bias Distribution
- 68% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage